Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Sepsis: Personalized Medicine Utilizing 'Omic' Technologies-A Paradigm Shift?

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Den unge forsker som vejleder - er forudsætningerne i orden

    Publikation: Bidrag til tidsskriftBidrag til avis - KronikFormidling

Vis graf over relationer

Sepsis has over the years proven a considerable challenge to physicians and researchers. Numerous pharmacological and non-pharmacological interventions have been tested in trials, but have unfortunately failed to improve the general prognosis. This has led to the speculation that the sepsis population may be too heterogeneous to be targeted with the traditional one treatment suits all' approach. Recent advances in genetic and biochemical analyses now allow genotyping and biochemical characterisation of large groups of patients via the 'omics' technologies. These new opportunities could lead to a paradigm shift in the approach to sepsis towards personalised treatments with interventions targeted towards specific pathophysiological mechanisms activated in the patient. In this article, we review the potentials and pitfalls of using new advanced technologies to deepen our understanding of the clinical syndrome of sepsis.

OriginalsprogEngelsk
TidsskriftHealthcare (Basel, Switzerland)
Vol/bind6
Udgave nummer3
Sider (fra-til)E111
ISSN2227-9032
DOI
StatusUdgivet - 7 sep. 2018

ID: 56537369